Cognition Therapeutics is a clinical-stage biopharmaceutical company leveraging our expertise in the σ-2 (sigma-2) receptor to develop innovative, small molecule therapeutics targeting age-related degenerative diseases. Our initial focus is on degenerative diseases of the CNS and retina such as Alzheimer’s disease, dementia with Lewy bodies and dry age-related macular degeneration.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Sep 29, 2022
Sep 27, 2022
Sep 06, 2022
Nov 30 - Dec 2, 2022
Nov 29 - Dec 2, 2022
Oct 7, 2022 from 9:00 AM to 10:00 AM PDT